International Journal of Radiation Oncology * Biology * Physics
Volume 47, Issue 5 , Pages 1169-1176 , 15 July 2000

Cyclin D1 expression and early breast cancer recurrence following lumpectomy and radiation

This work was presented, in part, at the 88th Annual meeting of the American Society for Therapeutic Radiology and Oncology,Oct. 31–Nov. 4, 1999 in San Antonio, TX.

  • Bruce C Turner, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology and the Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA
    • ,
  • Andrew A Gumbs, M.D.

      Affiliations

    • Department ofTherapeutic Radiology, Philadelphia, PA, USA
    • ,
  • Darryl Carter, M.D.

      Affiliations

    • Department ofPathology, Yale University School of Medicine, New Haven, CT, USA
    • ,
  • Peter M Glazer, M.D., Ph.D.

      Affiliations

    • Department ofTherapeutic Radiology, Philadelphia, PA, USA
    • ,
  • Bruce G Haffty, M.D.

      Affiliations

    • Department ofTherapeutic Radiology, Philadelphia, PA, USA
    • Corresponding Author InformationReprint requests to: Bruce G. Haffty, M.D., Department of Therapeutic Radiology, Yale University School of Medicine, P.O. Box 208040, New Haven, CT 06520-8040

,Accepted 10 February 2000.

References 

  1. Veronesi U, Saccozzi R, Del Vecchio M, et al.  Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med. 1981;305:6–11
  2. Fischer B, Redmond C, Poisson R, et al.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989;320:822–828
  3. Stotter AT, McNeese MD, Ames FC, et al.  Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer. 1989;64:2217–2225
  4. Haffty BG, Fischer D, Beinfield M, et al.  Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys. 1991;21:293–298
  5. Lichter AS, Lippman ME, Danforth D, et al.  Mastectomy versus breast conserving therapy in the treatment of stage I and II carcinoma of the breast (A randomized trial at the National Cancer Institute). J Clin Oncol. 1992;10:976–983
  6. Haffty BG, Reiss M, Beinfield M, et al.  Ipsilateral breast tumor recurrence as a predictor of distant disease (Implications for systemic therapy at the time of local relapse). J Clin Oncol. 1996;14:52–57
  7. Fourquet A, Campana F, Zafrani B, et al.  Prognostic factors in the conservative management of early breast cancer (A 25 year follow-up at the Institute Curie). Int J Radiat Oncol Biol Phys. 1989;17:719–725
  8. Kurtz JM, Jacquemier J, Amalric R, et al.  Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer. 1990;65:1867–1878
  9. Kurtz JM, Spitalier JM, Amalric R, et al.  Mammary recurrences in women younger than forty. Int J Radiat Oncol Biol Phys. 1988;15:271–276
  10. Borger J, Kemperman H, Hart A, et al.  Risk factors in breast-conservation therapy. J Clin Oncol. 1994;12:653–660
  11. Schnitt SJ, Connolly JL, Harris JR; et al. Pathologic predictors or early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer 53;1049–1057.
  12. Turner BC, Haffty BG, Narayanan L, et al.  Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res. 1997;57:3079–3083
  13. Haffty BG, Brown F, Carter D, et al.  Evaluation of HER-2 NEU oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer (A case-control study). Int J Radiat Oncol Biol Phys. 1996;35:751–757
  14. Buckley MF, Sweeney KJ, Hamilton JA, et al.  Expression and amplification of cyclin genes in human breast cancer. Oncogene. 1993;8:2127–2133
  15. Bartkova J, Lukas J, Muller H, et al.  Cyclin D1 protein expression and function in human breast cancer. Int J Cancer. 1994;57:353–361
  16. Gillett C, Fantl V, Smith R, et al.  Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 1994;54:1812–1817
  17. Musgrove EA, Lee CS, Buckley MF, et al.  Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci USA. 1994;91:8022–8026
  18. Bartkov J, Lukas J, Strauss M, et al.  Cell cycle variation and tissue-restricted expression of human cyclin D1 protein. J Pathol. 1994;172:237–245
  19. Quelle DE, Ashmun RA, Shurtleff SA, et al.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Devel. 1993;7:1559–1571
  20. Kranenburg O, van der Eb AJ, Zantema A: Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J 1996;15:46–54.
  21. de Jong JS, van Diest PJ, Michalides RJ, et al.  Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer. Mol Path. 1998;51:30–34
  22. Wang TC, Cardiff RD, Zukerberg L, et al.  Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 1994;369:669–671
  23. Martin Coco JM, Balkenende A, Verschoor T, et al.  Cyclin D1 overexpression enhances radiation-induced apoptosis and radiosensitivity in a breast tumor cell line. Cancer Res. 1999;59:1134–1140
  24. Gillett C, Smith P, Gregory W, et al.  Cyclin D1 and prognosis in human breast cancer. Int J Cancer. 1996;69:92–99
  25. McIntosh GG, Anderson JJ, Milton I, et al.  Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene. 1995;11:885–891
  26. Schuuring E, Verhoeven E, van Tinteren H. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res. 1992;52:5229–5234
  27. Maher MG, Sapi E, Turner B, et al.  Prognostic significance of colony-stimulating factor expression in ipsilateral breast cancer recurrence. Clin Cancer Res. 1998;4:1851–1856
  28. King WJ, DeSombre ER, Jensen EV, et al.  Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors. Cancer Res. 1985;45:293–296
  29. Haffty BG, Carter D, Flynn SG, et al.  Local recurrence versus new primary (Clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting). Int J Radiat Oncol Biol Phys. 1993;27:575–583
  30. Weinstat-Saslow D, Merino MJ, Manrow RE, et al.  Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med. 1995;1:1257–1260
  31. Peters G, Fantl V, Smith R, et al.  Chromosome 11q13 markers and D-type cyclins in breast cancer. Breast Cancer Res Treat. 1995;33:125–135
  32. Hui R, Cornish AL, McClelland RA, et al.  Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. Clinical Cancer Res. 1996;2:923–928
  33. Kurtz JM, Spitalier JM, Amalric R, et al.  The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys. 1990;18:87–93

PII: S0360-3016(00)00525-3

doi: 10.1016/S0360-3016(00)00525-3

International Journal of Radiation Oncology * Biology * Physics
Volume 47, Issue 5 , Pages 1169-1176 , 15 July 2000

Article Tools

* Image Usage & Resolution